[1]
“BRAFV600E MUTATION IN PAPILLARY THYROID CARCINOMA. CLINICAL AND METHODOLOGICAL ASPECTS”, Вопр. онкол., vol. 65, no. 1, pp. 16–26, Jan. 2019, doi: 10.37469/0507-3758-2019-65-1-16-26.